A recent study reported that miR-34a, which was upregulated by p53 during the activation of DNA repairing response, repressed Foxp1 and subsequently reduced the propensity of BCR signaling in CLL cells (141). Here, TP53 is linked to B-cell chronic lymphocytic leukemia.